SMPD2
Basic information
Region (hg38): 6:109440724-109443919
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMPD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 23 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 2 | 1 |
Variants in SMPD2
This is a list of pathogenic ClinVar variants found in the SMPD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-109441144-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
6-109441365-C-T | not specified | Uncertain significance (Apr 18, 2023) | ||
6-109441381-C-G | not specified | Uncertain significance (Sep 17, 2021) | ||
6-109441436-C-G | not specified | Uncertain significance (Nov 30, 2022) | ||
6-109442017-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
6-109442285-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
6-109442774-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
6-109442786-T-G | not specified | Uncertain significance (Sep 30, 2024) | ||
6-109442830-G-C | Benign (Apr 07, 2018) | |||
6-109442853-A-G | not specified | Likely benign (Dec 04, 2021) | ||
6-109442864-C-G | not specified | Uncertain significance (Jul 25, 2024) | ||
6-109442977-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
6-109443020-T-C | not specified | Uncertain significance (Jun 21, 2023) | ||
6-109443023-G-C | not specified | Uncertain significance (Oct 20, 2023) | ||
6-109443325-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
6-109443346-C-G | not specified | Uncertain significance (Jan 24, 2024) | ||
6-109443360-C-A | not specified | Uncertain significance (May 25, 2022) | ||
6-109443363-A-G | not specified | Uncertain significance (Feb 11, 2022) | ||
6-109443394-C-A | not specified | Uncertain significance (May 26, 2022) | ||
6-109443535-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
6-109443552-A-C | not specified | Uncertain significance (May 14, 2024) | ||
6-109443558-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
6-109443579-G-C | not specified | Uncertain significance (Jan 23, 2023) | ||
6-109443613-C-T | not specified | Uncertain significance (Apr 26, 2024) | ||
6-109443683-C-T | Likely benign (Apr 07, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMPD2 | protein_coding | protein_coding | ENST00000258052 | 10 | 3157 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.55e-18 | 0.00135 | 125610 | 0 | 138 | 125748 | 0.000549 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.143 | 230 | 236 | 0.974 | 0.0000122 | 2754 |
Missense in Polyphen | 47 | 55.455 | 0.84754 | 652 | ||
Synonymous | -0.129 | 100 | 98.4 | 1.02 | 0.00000542 | 850 |
Loss of Function | -0.589 | 25 | 22.0 | 1.14 | 0.00000101 | 239 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00127 | 0.00127 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000707 | 0.000653 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000528 | 0.000528 |
Middle Eastern | 0.000707 | 0.000653 |
South Asian | 0.00101 | 0.00101 |
Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Converts sphingomyelin to ceramide. Hydrolyze 1-acyl-2- lyso-sn-glycero-3-phosphocholine (lyso-PC) and 1-O-alkyl-2-lyso- sn-glycero-3-phosphocholine (lyso-platelet-activating factor). The physiological substrate seems to be Lyso-PAF.;
- Pathway
- Sphingolipid signaling pathway - Homo sapiens (human);Sphingolipid metabolism - Homo sapiens (human);TNF alpha Signaling Pathway;Signal Transduction of S1P Receptor;Signal Transduction;phospholipids as signalling intermediaries;Metabolism of lipids;sphingomyelin metabolism/ceramide salvage;Metabolism;Glycosphingolipid metabolism;TNFR1-mediated ceramide production;TNF signaling;Death Receptor Signalling;Ceramide signalling;p75 NTR receptor-mediated signalling;Glycosphingolipid metabolism;Sphingolipid metabolism;TNF receptor signaling pathway ;p75(NTR)-mediated signaling
(Consensus)
Recessive Scores
- pRec
- 0.293
Intolerance Scores
- loftool
- 0.664
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.36
Haploinsufficiency Scores
- pHI
- 0.0717
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.507
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.795
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Smpd2
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- sphingomyelin metabolic process;response to mechanical stimulus;intracellular signal transduction;ceramide biosynthetic process;positive regulation of ceramide biosynthetic process
- Cellular component
- plasma membrane;integral component of plasma membrane;caveola
- Molecular function
- sphingomyelin phosphodiesterase activity;metal ion binding